⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNSE News
Sensei Biotherapeutics, Inc. Common Stock
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SNSE
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SNSE
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
businesswire.com
SNSE
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
businesswire.com
SNSE
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
businesswire.com
SNSE
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
globenewswire.com
SNSE
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
globenewswire.com
SNSE
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
globenewswire.com
SNSE
Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025
globenewswire.com
SNSE